Budget Range
Min
€1,500
Average
€35,990
Max
€176,610
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (19)
P
GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD
Health101112066
€176,610
P
PANcreatic CAncer Initial Detection via liquid biopsy
HORIZON.2.1101096309
€98,388
P
A European-wide foundation to accelerate Data-driven Cancer Research
Research Infrastructures101058427
€78,145
P
Respiratory Host-Pathogen Interaction
HORIZON.2.1101057129
€75,973
P
Accelerating datafication for support of EU health priorities, greening of biobanks and integrated approach to “One Health”
Research Infrastructures101131701
€40,000
P
Metabolic control of cell growth by mTOR in health and disease: a multi-disciplinary training
MSCA (Marie Skłodowska-Curie)101168624
€39,540
P
From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
MSCA (Marie Skłodowska-Curie)101081481
€37,632
C
Retrograde atrophy induction: a paradigm shift in prostate and pancreatic cancer prevention and therapy.
HORIZON.3.1101258103
€31,406
P
DNA replication at the heart of cell fate decisions and cancer development
MSCA (Marie Skłodowska-Curie)101072903
€26,503
P
Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases
MSCA (Marie Skłodowska-Curie)101072505
€26,498
P
PUBLIC ENGAGEMENT IN RESEARCH INFRASTRUCTURES FOR MISSION CANCER: MANAGING COMPLEXITY OF EMERGING TECHNOLOGIES
Health101216808
€23,623
C
Co-option of host circadian rhythms in cancer
HORIZON.1.1101115811
€15,000
P
Researchers and citizen creating together a better future
HORIZON.1.2101162110
€3,374
P
Researchers and citizens: facing together the European challenges
MSCA (Marie Skłodowska-Curie)101061343
€3,000
C
Targeting R2TP/TTT/WAC/mTOR complex in ovarian cancer.
MSCA (Marie Skłodowska-Curie)101105041
€1,812
C
NUTRIENT FLUCTUATIONS AND THE INTEGRATIVE STRESS RESPONSE AS METABOLIC CELL FATE DETERMINANTS IN B CELL LYMPHOMA
MSCA (Marie Skłodowska-Curie)101108401
€1,653
C
Integrating longitudinal multi-modal profiling of metastatic breast cancer patients for high-definition oncology
HORIZON.1.2101155328
€1,653
C
Targeting intracelular RANKL in breast cancer
HORIZON.1.1101202409
€1,500
C
Targeting RANK receptor as a novel therapeutic strategy in triple negative breast cancer
HORIZON.1.1101062190
€1,500